OneDigital Investment Advisors’s Neurocrine Biosciences NBIX Stock Holding History

OneDigital Investment Advisors’s Portfolio NBIX Stock Details NBIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$589K	Sell	3,493 -9	-0.3%	-$1.33K	0.01%	974
2026 Q1	$461K	Sell	3,502 -379	-10%	-$50.3K	﹤0.01%	983
2025 Q4	$550K	Sell	3,881 -355	-8%	-$51.4K	0.01%	907
2025 Q3	$595K	Sell	4,236 -491	-10%	-$66.5K	0.01%	854
2025 Q2	$594K	Buy	4,727 +504	+12%	+$57.8K	0.01%	837
2025 Q1	$467K	Buy	4,223 +8	+0.2%	+$1.01K	0.01%	887
2024 Q4	$575K	Buy	4,215 +87	+2%	+$10.8K	0.01%	836
2024 Q3	$476K	Sell	4,128 -893	-18%	-$122K	0.01%	957
2024 Q2	$691K	Buy	5,021 +3,030	+152%	+$416K	0.01%	765
2024 Q1	$275K	Buy	+1,991	New	+$272K	﹤0.01%	939
2021 Q2	–	Sell	-2,172	Closed	-$211K	–	770
2021 Q1	$211K	Buy	+2,172	New	+$228K	0.01%	601

Other funds holding NBIX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return

OneDigital Investment Advisors's NBIX Position: Q2 2026 in Review

OneDigital Investment Advisors reduced its Neurocrine Biosciences (NBIX) stake by 0.26% in Q2 2026, selling an estimated $1.33K and leaving 3,493 shares worth $589K. The position accounts for 0.01% of the portfolio, ranked #974.

OneDigital Investment Advisors first reported a position in NBIX in Q1 2021 and has held it in 11 quarters since. The position peaked at $691K in Q2 2024. 525 funds tracked by Wall St. Rank hold NBIX as of Q2 2026.

OneDigital Investment Advisors held 3,493 shares of Neurocrine Biosciences worth $589K as of Q2 2026.
OneDigital Investment Advisors sold 9 Neurocrine Biosciences shares in Q2 2026, an estimated $1.33K.
Neurocrine Biosciences made up 0.01% of OneDigital Investment Advisors's portfolio in Q2 2026, its #974 holding.
OneDigital Investment Advisors first reported a position in Neurocrine Biosciences in Q1 2021 and has held it in 11 quarters since.
OneDigital Investment Advisors's Neurocrine Biosciences position peaked at $691K in Q2 2024.
525 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2026.

Based on OneDigital Investment Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.